Subscribe or Manage Preferences

Giant Cell Arteritis

Treatment with abatacept plus a prednisone taper significantly reduced the rate of relapse and improved duration of remission compared with placebo in patients with giant cell arteritis (GCA) who achieved remission with abatacept plus prednisone.

Tocilizumab treatment weekly or every other week for 52 weeks with a 26-week prednisone taper was superior to a short and long course of tapered prednisone treatment in patients with giant cell arteritis (GCA).

Results 1 - 2 of 2
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology